| Wed, Jun 17, 2009 | | • | Penwest Enters Into Third Research and Development Agreement With Otsuka Pharmaceutical
GlobeNewswire (Wed, Jun 17)
| | Wed, Jun 10, 2009 | | • | Penwest Announces Preliminary Vote Count At Annual Meeting
GlobeNewswire (Wed, Jun 10)
| | Tue, Jun 9, 2009 | | • | Penwest Urges Shareholders to Vote the White Proxy Card Today and Reject Dissident Proposals and Nominees At Wednesday's Annual Meeting
GlobeNewswire (Tue, Jun 9)
| | • | Penwest and Endo Grant Valeant Pharmaceuticals Exclusive License to Market Opana(r) ER in Canada, Australia and New Zealand
GlobeNewswire (Tue, Jun 9)
| | Mon, Jun 1, 2009 | | • | Leading Proxy Advisory Firms RiskMetrics Group and Glass Lewis Recommend Penwest Shareholders Vote Against All Three Dissident Proxy Proposals
GlobeNewswire (Mon, Jun 1)
| | Fri, May 22, 2009 | | • | Washington State Court Denies Dissidents' Request for Preliminary Injunction in Penwest Proxy Vote
GlobeNewswire (Fri, May 22)
| | Tue, May 19, 2009 | | • | Penwest Urges Shareholders to Reject Tang Capital and Perceptive's Wind Down Proposal
GlobeNewswire (Tue, May 19)
| | Mon, May 11, 2009 | | • | PENWEST PHARMACEUTICALS CO Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon, May 11)
| | Thu, May 7, 2009 | | • | Penwest Files Definitive Proxy Materials in Connection With June 10 Annual Meeting
GlobeNewswire (Thu, May 7)
| | • | PENWEST PHARMACEUTICALS CO Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Thu, May 7)
| | • | Penwest Reports First Quarter 2009 Financial Results
GlobeNewswire (Thu, May 7)
| | Wed, Apr 29, 2009 | | • | Penwest First Quarter 2009 Financial Results Conference Call
GlobeNewswire (Wed, Apr 29)
| | Thu, Mar 26, 2009 | | • | Latest News in Activist Investing
at TheStreet.com (Thu, Mar 26)
| | Mon, Mar 16, 2009 | | • | PENWEST PHARMACEUTICALS CO Files SEC form 10-K, Annual Report
EDGAR Online (Mon, Mar 16)
| | Thu, Mar 12, 2009 | | • | PENWEST PHARMACEUTICALS CO Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to R
EDGAR Online (Thu, Mar 12)
| | • | Penwest Sends Letter to Shareholders On Financial, Business and Corporate Governance Developments
GlobeNewswire (Thu, Mar 12)
| | Wed, Mar 11, 2009 | | • | Penwest to Present At Cowen & Company 29th Annual Healthcare Conference
GlobeNewswire (Wed, Mar 11)
| | Wed, Mar 4, 2009 | | • | PENWEST PHARMACEUTICALS CO Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Wed, Mar 4)
| | • | Penwest Reports Fourth Quarter and Year End 2008 Financial Results
GlobeNewswire (Wed, Mar 4)
| | • | Penwest Reports Fourth Quarter and Year End 2008 Financial Results
GlobeNewswire (Wed, Mar 4)
| | Wed, Feb 25, 2009 | | • | Penwest Begins Phase Ib Clinical Trial of A0001, Dosing Underway of Compound for the Treatment of Mitochondrial Diseases
GlobeNewswire (Wed, Feb 25)
| | Mon, Feb 23, 2009 | | • | Penwest Fourth Quarter and Year End 2008 Financial Results Conference Call
GlobeNewswire (Mon, Feb 23)
| | Wed, Feb 4, 2009 | | • | Penwest to Present At 11th Annual BIO CEO & Investor Conference
GlobeNewswire (Wed, Feb 4)
| | Tue, Feb 3, 2009 | | • | PENWEST PHARMACEUTICALS CO Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Tue, Feb 3)
| | Mon, Jan 26, 2009 | | • | PENWEST PHARMACEUTICALS CO Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Mon, Jan 26)
|
Add PPCO News to My Yahoo!:
 
| |
|
0.11% Nasdaq 
0.04 (1.56%) 
Headlines
